Cite
HARVARD Citation
Garrido‐Cano, I. et al. (2022). MiR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies. Cancer communications. 42 (12), pp. 1412-1416. [Online].